Electra Therapeutics Inc.(ETRA)

Medical - Pharmaceuticals · South San Francisco, CA

$9.53-0.21 (-2.16%)

Delayed quote: Oct 6, 2026, 9:34 AM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T13:36:31.237Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:36:31.237Z.

Quote observation: 2026-10-06T13:34:24.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 202,155,125
Total debt: N/A
Cash: N/A
TTM free cash flow: N/A

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ETRA EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

ETRA Competitors' EV/FCF Ratio

ETRA

Electra Therapeutics Inc.

Current

Market Cap

$202.16M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ANTX

AN2 Therapeutics, Inc.

vs ETRA

Market Cap

$198.09M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELDN

Eledon Pharmaceuticals, Inc.

vs ETRA

Market Cap

$194.51M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CGEN

Compugen Ltd.

vs ETRA

Market Cap

$219.84M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DERM

Journey Medical Corporation

vs ETRA

Market Cap

$184.12M

EV/FCF Ratio

N/A

TTM Avg

72.04x

3Y Avg

55.57x

5Y Avg

55.57x

KROS

Keros Therapeutics, Inc.

vs ETRA

Market Cap

$230.09M

EV/FCF Ratio

N/A

TTM Avg

0.76x

3Y Avg

0.76x

5Y Avg

0.76x

CNTN

Canton Strategic Holdings Inc

vs ETRA

Market Cap

$180.08M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALEC

Alector, Inc.

vs ETRA

Market Cap

$230.93M

EV/FCF Ratio

N/A

TTM Avg

2.29x

3Y Avg

2.30x

5Y Avg

3.66x

CMPX

Compass Therapeutics, Inc.

vs ETRA

Market Cap

$171.10M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DTIL

Precision BioSciences, Inc.

vs ETRA

Market Cap

$175.27M

EV/FCF Ratio

N/A

TTM Avg

277.79x

3Y Avg

277.79x

5Y Avg

277.79x

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Electra Therapeutics Inc. (ETRA)	$202.16M	N/A	N/A	N/A	N/A
AN2 Therapeutics, Inc. (ANTX)vs ›	$198.09M	N/A	N/A	N/A	N/A
Eledon Pharmaceuticals, Inc. (ELDN)vs ›	$194.51M	N/A	N/A	N/A	N/A
Compugen Ltd. (CGEN)vs ›	$219.84M	N/A	N/A	N/A	N/A
Journey Medical Corporation (DERM)vs ›	$184.12M	N/A	72.04x	55.57x	55.57x
Keros Therapeutics, Inc. (KROS)vs ›	$230.09M	N/A	0.76x	0.76x	0.76x
Canton Strategic Holdings Inc (CNTN)vs ›	$180.08M	N/A	N/A	N/A	N/A
Alector, Inc. (ALEC)vs ›	$230.93M	N/A	2.29x	2.30x	3.66x
Compass Therapeutics, Inc. (CMPX)vs ›	$171.10M	N/A	N/A	N/A	N/A
Precision BioSciences, Inc. (DTIL)vs ›	$175.27M	N/A	277.79x	277.79x	277.79x

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

ETRA EV/FCF Ratio Metrics

ETRA Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics